Primary Osteoporosis in Postmenopausal Women

Overview

Journal Chronic Dis Transl Med

Publisher Wiley

Date 2017 Oct 25

PMID 29062981

Citations 186

Authors

Meng-Xia Ji

Qi Yu

Affiliations

Soon will be listed here.

Citing Articles

Relationship between bone mineral density and oral health: a cross sectional observational study.

Erdem R, Erdem M, Kiranatli M, Karakaya K BMC Oral Health. 2025; 25(1):250.

PMID: 39966828 PMC: 11834507. DOI: 10.1186/s12903-025-05642-x.

Effects of Anticancer Therapy on Osteoporosis in Breast Cancer Patients: A Nationwide Study Using Data from the National Health Insurance Service-National Health Information Database.

Kwon M, Kim B, Min S, Chae S J Clin Med. 2025; 14(3).

PMID: 39941403 PMC: 11818878. DOI: 10.3390/jcm14030732.

The role of dietary inflammation in the risk of osteoporosis in Iranian postmenopausal women: a case-control study.

Ghadiri M, Pourghassem Gargari B, Ahmadi M, Nouri M, Shateri Z, Naeini A Sci Rep. 2025; 15(1):5120.

PMID: 39934201 PMC: 11814271. DOI: 10.1038/s41598-025-89649-y.

Osteoporosis: Causes, Mechanisms, Treatment and Prevention: Role of Dietary Compounds.

Stromsnes K, Martinez Fajardo C, Soto-Rodriguez S, Kajander E, Lupu R, Pozo-Rodriguez M Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770539 PMC: 11679375. DOI: 10.3390/ph17121697.

The Effects of Gender on Mesenchymal Stromal Cell (MSC) Proliferation and Differentiation In Vitro: A Systematic Review.

Vogt A, Faher A, Kucharczak J, Birch M, McCaskie A, Khan W Int J Mol Sci. 2025; 25(24.

PMID: 39769346 PMC: 11677156. DOI: 10.3390/ijms252413585.

References

Burge R, Dawson-Hughes B, Solomon D, Wong J, King A, Tosteson A . Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res. 2006; 22(3):465-75. DOI: 10.1359/jbmr.061113. View

Schierbeck L, Rejnmark L, Tofteng C, Stilgren L, Eiken P, Mosekilde L . Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ. 2012; 345:e6409. DOI: 10.1136/bmj.e6409. View

Sandhu S, Hampson G . The pathogenesis, diagnosis, investigation and management of osteoporosis. J Clin Pathol. 2011; 64(12):1042-50. DOI: 10.1136/jcp.2010.077842. View

Wasnich R, Bagger Y, Hosking D, McClung M, Wu M, Mantz A . Changes in bone density and turnover after alendronate or estrogen withdrawal. Menopause. 2004; 11(6 Pt 1):622-30. DOI: 10.1097/01.gme.0000123641.76105.b5. View

Sapre S, Thakur R . Lifestyle and dietary factors determine age at natural menopause. J Midlife Health. 2014; 5(1):3-5. PMC: 3955043. DOI: 10.4103/0976-7800.127779. View

Lewiecki E . Prevention and treatment of postmenopausal osteoporosis. Obstet Gynecol Clin North Am. 2008; 35(2):301-15, ix. DOI: 10.1016/j.ogc.2008.03.007. View

Cauley J, Robbins J, Chen Z, Cummings S, Jackson R, LaCroix A . Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA. 2003; 290(13):1729-38. DOI: 10.1001/jama.290.13.1729. View

Bonjour J, Theintz G, Law F, Slosman D, Rizzoli R . Peak bone mass. Osteoporos Int. 1994; 4 Suppl 1:7-13. DOI: 10.1007/BF01623429. View

Lindsay R, Gallagher J, Kleerekoper M, Pickar J . Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women. JAMA. 2002; 287(20):2668-76. DOI: 10.1001/jama.287.20.2668. View

10.

Kanis J, Melton 3rd L, Christiansen C, JOHNSTON C, Khaltaev N . The diagnosis of osteoporosis. J Bone Miner Res. 1994; 9(8):1137-41. DOI: 10.1002/jbmr.5650090802. View

11.

Rogers A, Saleh G, Hannon R, Greenfield D, Eastell R . Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women. J Clin Endocrinol Metab. 2002; 87(10):4470-5. DOI: 10.1210/jc.2002-020396. View

12.

Cummings S, Ettinger B, Delmas P, Kenemans P, Stathopoulos V, Verweij P . The effects of tibolone in older postmenopausal women. N Engl J Med. 2008; 359(7):697-708. PMC: 3684062. DOI: 10.1056/NEJMoa0800743. View

13.

Wells G, Tugwell P, Shea B, Guyatt G, Peterson J, Zytaruk N . Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocr Rev. 2002; 23(4):529-39. DOI: 10.1210/er.2001-5002. View

14.

Cooper C, Cole Z, Holroyd C, Earl S, Harvey N, Dennison E . Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int. 2011; 22(5):1277-88. PMC: 3546313. DOI: 10.1007/s00198-011-1601-6. View

15.

Garnero P, Sornay-Rendu E, Duboeuf F, Delmas P . Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the OFELY study. J Bone Miner Res. 1999; 14(9):1614-21. DOI: 10.1359/jbmr.1999.14.9.1614. View

16.

Johnell O . The socioeconomic burden of fractures: today and in the 21st century. Am J Med. 1997; 103(2A):20S-25S; discussion 25S-26S. DOI: 10.1016/s0002-9343(97)90023-1. View

17.

Cawthon P . Gender differences in osteoporosis and fractures. Clin Orthop Relat Res. 2011; 469(7):1900-5. PMC: 3111766. DOI: 10.1007/s11999-011-1780-7. View

18.

Greendale G, Sowers M, Han W, Huang M, Finkelstein J, Crandall C . Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: results from the Study of Women's Health Across the Nation (SWAN). J Bone Miner Res. 2011; 27(1):111-8. PMC: 3378821. DOI: 10.1002/jbmr.534. View

19.

Lerner U . Bone remodeling in post-menopausal osteoporosis. J Dent Res. 2006; 85(7):584-95. DOI: 10.1177/154405910608500703. View

20.

Cauley J . Defining ethnic and racial differences in osteoporosis and fragility fractures. Clin Orthop Relat Res. 2011; 469(7):1891-9. PMC: 3111798. DOI: 10.1007/s11999-011-1863-5. View